Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, Benjamin Ruf, Yuta Myojin, Kylynda C. Bauer, Patrick Huang, Chi Ma, Marina Villamor-Payà, Francisco Rodríguez-Matos, Marlaine Soliman, Rajiv Trehan, Cecilia Monge, Changqing Xie, David E. Kleiner, Bradford J. Wood, Elliot Levy, Anuradha Budhu, Noémi Kedei, Christian T. Mayer, Xin Wei Wang, Justin Lack, William G. Telford, Firouzeh Korangy, Tim F. Greten
Topics & Concepts
BlockadeReprogrammingBiologyImmune checkpointImmunologyCancer researchB-cell activating factorImmune systemImmunotherapyReceptorAntibodyCellGeneticsBiochemistryB cellImmune cells in cancerCancer Immunotherapy and BiomarkersAngiogenesis and VEGF in Cancer